Application of interleukin-2-secreting syngeneic/allogeneic fibroblasts in the treatment of primary and metastatic brain tumors

Cancer Gene Therapy

Volumn 9, Issue 5, 2002, Pages 464-469

  Lichtor, Terry ^a   Glick, Roberta P ^a,b   Tarlock, Katherine ^a   Moffett, Shannon ^a   Mouw, Elizabeth ^a   Cohen, Edward P ^b  

^a Hektoen Institute for Medical Research   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Breast cancer; Gene therapy; Glioma; IL 2; Tumor vaccine

Indexed keywords

ANIMALS; BRAIN NEOPLASMS; BREAST NEOPLASMS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FIBROBLASTS; GENE TRANSFER TECHNIQUES; GLIOMA; HUMANS; INTERLEUKIN-2; MICE; MICE, INBRED C3H; MICE, INBRED C57BL; NEOPLASM TRANSPLANTATION; TIME FACTORS; TUMOR CELLS, CULTURED;

INTERLEUKIN 2; TUMOR VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN TUMOR; BREAST CANCER; CANCER GROWTH; CANCER IMMUNIZATION; CANCER PREVENTION; CANCER SURVIVAL; CARCINOMA CELL; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; FEMALE; FIBROBLAST; GENE THERAPY; GLIOMA; GLIOMA CELL; METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR IMMUNITY;

ANIMALIA;

EID: 85047697227     PISSN: 09291903     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.cgt.7700459     Document Type: Article

References (23)

1. Induction of potent antitumor CTL responses by recombinant vaccinia encoding a melan-A peptide analogue
2. Hematopoietic growth factors: Biology and clinical application
3. Cytokines: Structure function and synthesis
4. Lymphokines and cytokines as cancer treatment. Immunotherapy realized
5. New approaches to the immunotherapy of cancer
6. High-dose recombinant interleukin-2 in the treatment of patients with disseminated cancer: Responses, treatment -related morbidity and histologic findings
7. Intralymphatic administration of interleukin-2 (IL-2) in cancer patients: A pilot study
8. A pilot study of intralymphatic interleukin-2: II. Clinical and biological effects
9. Intratumoral echo-guided injection of interleukin-2 and cytokine-activated killer cells in hepatocellular carcinoma
10. Local administration of cells containing an inserted IL-2 gene and producing IL-2 inhibits growth of human tumors in nu/nu mice
11. Interleukin-2-secreting mouse fibroblasts transfected with genomic DNA from murine melanoma cells prolong the survival of mice with melanoma
12. Immunity to B 16 melanoma in mice immunized with IL-2-secreting allogeneic mouse fibroblasts expressing melanoma-associated antigens
13. Fibroblasts genetically engineered to secrete interleukin 12 can suppress tumor growth and induce antitumor immunity to a murine melanoma in vivo
14. Cytokine gene therapy with interleukin-2 transduced fibroblasts: Effects of IL-2 dose on anti-tumor immunity
15. Interleukin-2 gene therapy in a patient with glioblastoma
16. Prolonged survival of mice with glioma injected intracerebrally with double cytokine-secreting cells
17. Immunogene therapy with interleukin-2-secreting fibroblasts for intracerebrally metastasizing breast cancer in mice
18. Retroviral expression of the human IL-2 gene in a murine T cell line results in a cell growth autonomy and tumorigenicity
19. A new dominant hybrid selective marker for eucaryotic cells
20. Construction and use of a safe and efficient amphotropic packaging cell line
21. Development of a new mouse brain tumor model using implantable micro-cannulas
22. Prolongation of survival of mice with glioma treated with semiallogeneic fibroblasts secreting interleukin-2
23. Tumor rejection mediated by transfection with allogeneic class I histocompatibility gene